Online citations, reference lists, and bibliographies.
← Back to Search

Proteomics Of Transplant Rejection

C. McManus, M. Rose, M. J. Dunn
Published 2006 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Although the number of patients receiving successful transplantation as a means of treatment for end-stage organ failure continues to increase, rejection, in particular chronic rejection still poses a major risk factor. Crucially, only 50% of allografted hearts and kidneys survive for 10 years. Currently, biopsy is the most common and, in some instances, the only means of diagnosing rejection: it is both invasive and costly. A blood or urine biomarker would overcome these problems and conceivably enable diagnosis of rejection far earlier than a biopsy because it could be diagnosed before clinical symptoms. Furthermore, development of a biomarker could lead to new insights into the disease process. In recent years, proteomics has provided a novel means of examining potential biomarkers. We discuss here the various proteomic platforms available, including 2-dimensional gel electrophoresis, mass spectrometry, and protein arrays, and the various studies exploring protein profiling in heart, lung, kidney, and liver transplantation.
This paper references
10.1017/CBO9780511545962
Biomarkers of disease: an evidence-based approach.
A. Trull (2002)
10.1016/S1367-5931(02)00009-1
Tackling the phosphoproteome: tools and strategies.
D. Kalume (2003)
10.1097/01.tp.0000190423.82154.01
Chronic Allograft Nephropathy: Current Concepts and Future Directions
B. Nankivell (2006)
10.1002/PMIC.200401036
Proteomic identification of human neutrophil alpha‐defensins in chronic lung allograft rejection
G. Nelsestuen (2005)
10.1016/J.LFS.2004.01.028
High concentrations of α-defensins in plasma and bronchoalveolar lavage fluid of patients with acute respiratory distress syndrome
J. Ashitani (2004)
10.1002/pmic.200390037
Evaluation of nonionic and zwitterionic detergents as membrane protein solubilizers in two‐dimensional electrophoresis
S. Luche (2003)
10.1016/S0140-6736(02)07746-2
Use of proteomic patterns in serum to identify ovarian cancer
E. Petricoin (2002)
DRUGS AND BEHAVIOUR.
Yasargil Ec (1964)
10.1002/PMIC.200390006
A novel experimental design for comparative two‐dimensional gel analysis: Two‐dimensional difference gel electrophoresis incorporating a pooled internal standard
A. Alban (2003)
10.1152/ajplung.1998.275.2.L348
Clara cell secretory protein deficiency increases oxidant stress response in conducting airways.
G. Mango (1998)
10.1017/CBO9780511545962.042
Biomarkers of Disease: Monitoring heart and lung transplant patients
M. Rose (2002)
10.1186/ar122
Insights into rheumatoid arthritis derived from the Sa immune system
H. Ménard (2000)
10.1097/00007890-200105150-00024
SERIAL EVALUATION OF CELL SURFACE MARKERS FOR IMMUNE ACTIVATION AFTER ACUTE RENAL ALLOGRAFT REJECTION BY URINE FLOW CYTOMETRY: Correlation with Clinical Outcome1
I. Roberti (2001)
10.1093/CLINCHEM/48.8.1296
Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer.
J. Li (2002)
10.1083/JCB.17.2.375
JUNCTIONAL COMPLEXES IN VARIOUS EPITHELIA
M. Farquhar (1963)
10.1161/01.CIR.96.12.4343
Small heat shock proteins and protection against ischemic injury in cardiac myocytes.
J. Martin (1997)
10.1007/s00395-004-0483-6
Heat shock protein 27 protects the heart against myocardial infarction
C. Efthymiou (2004)
10.1002/RCM.1294
Mass spectrometry for the detection of differentially expressed proteins: a comparison of surface-enhanced laser desorption/ionization and capillary electrophoresis/mass spectrometry.
N. Neuhoff (2004)
10.1002/JCP.1041510316
Induced thermotolerance to apoptosis in a human T lymphocyte cell line
D. D. Mosser (1992)
10.1038/86783
Enrichment analysis of phosphorylated proteins as a tool for probing the phosphoproteome
Y. Oda (2001)
10.1002/PMIC.200300600
Protein microarrays: Promising tools for proteomic research
M. Templin (2003)
10.1136/bmj.289.6440.284
Comparison of reliability of tests to distinguish upper from lower urinary tract infection.
G. Schardijn (1984)
10.1111/j.1600-6143.2004.00360.x
Predicting Kidney Graft Failure by HLA Antibodies: a Prospective Trial
P. Terasaki (2004)
10.1002/ELPS.200500777
The human heart proteome: Two‐dimensional maps using narrow‐range immobilised pH gradients
J. A. Westbrook (2006)
10.1002/PMIC.200401293
Profiling humoral autoimmune repertoire of dilated cardiomyopathy (DCM) patients and development of a disease‐associated protein chip
Sabine C. Horn (2006)
10.3109/08941939509023142
Noninvasive diagnosis of cardiac allograft rejection: the effect of procainamide.
J. E. Everett (1995)
10.1097/01.ASN.0000101031.52826.BE
Proteomic-based detection of urine proteins associated with acute renal allograft rejection.
S. Schaub (2004)
Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.
B. Adam (2002)
10.1038/nrd2006
Multiplexed protein measurement: technologies and applications of protein and antibody arrays
S. Kingsmore (2006)
10.1016/j.healun.2005.05.019
Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult lung and heart-lung transplant report--2005.
E. Trulock (2005)
10.4049/jimmunol.169.7.4046
Orderly Pattern of Development of the Autoantibody Response in (New Zealand White × BXSB)F1 Lupus Mice: Characterization of Target Antigens and Antigen Spreading by Two-Dimensional Gel Electrophoresis and Mass Spectrometry1
S. Thébault (2002)
10.1126/SCIENCE.281.5378.832
Role of IQGAP1, a target of the small GTPases Cdc42 and Rac1, in regulation of E-cadherin- mediated cell-cell adhesion.
S. Kuroda (1998)
10.1111/J.1464-410X.1994.TB07449.X
Analysis of factors associated with complications following renal transplant needle core biopsy.
I. Beckingham (1994)
10.1016/0140-6736(92)91832-S
Anti-endothelial antibodies and coronary artery disease after cardiac transplantation
M. Dunn (1992)
10.1515/CCLM.2005.225
SELDI-TOF-MS proteomics of breast cancer
C. Clarke (2005)
10.1016/S1053-2498(02)00398-4
Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria.
M. Estenne (2002)
10.1016/S0041-1345(98)01412-2
Postischemic reperfusion injury and allograft arteriosclerosis.
B. Fellström (1998)
10.1016/S0003-4975(97)01306-4
Are circulating adhesion molecules specifically changed in cardiac surgical patients?
J. Boldt (1998)
10.1038/nbt0303-255
Proteomic analysis of post-translational modifications
M. Mann (2003)
10.1002/HEP.510240512
Reperfusion damage to the bile canaliculi in transplanted human liver
J. Cutrin (1996)
10.1002/PMIC.200300877
Quantitative protein profiling using antibody arrays
R. Barry (2004)
10.1002/1615-9861(200205)2:5<486::AID-PROT486>3.0.CO;2-X
An improved formulation of SYPRO Ruby protein gel stain: Comparison with the original formulation and with a ruthenium II tris (bathophenanthroline disulfonate) formulation
K. Berggren (2002)
10.1161/01.RES.0000174815.10996.08
Heat Shock Protein 27 Is Associated With Freedom From Graft Vasculopathy After Human Cardiac Transplantation
A. D. De Souza (2005)
10.1056/NEJM200103293441301
Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine.
B. Li (2001)
10.1093/BFGP/4.1.16
Advances in clinical cancer proteomics: SELDI-ToF-mass spectrometry and biomarker discovery.
Volker Seibert (2005)
10.1006/EXCR.1996.0070
Heat shock proteins increase resistance to apoptosis.
Afshin Samali (1996)
10.1080/02648725.1996.10647923
Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it.
M. Wilkins (1996)
10.1073/PNAS.88.20.9156
The uvomorulin-anchorage protein alpha catenin is a vinculin homologue.
K. Herrenknecht (1991)
10.1016/J.YMETH.2004.08.016
Protein identification using 2D-LC-MS/MS.
C. Delahunty (2005)
The systemic inflammatory response syndrome and off-pump cardiac surgery.
M. Vallely (2001)
10.1111/j.1600-6143.2005.01053.x
Detection of Acute Tubulointerstitial Rejection by Proteomic Analysis of Urinary Samples in Renal Transplant Recipients
S. Wittke (2005)
10.1097/00063198-200003000-00009
Obliterative bronchiolitis after lung transplantation
A. Boehler (2000)
10.1016/S0272-6386(89)80087-3
Percutaneous needle biopsy of the transplanted kidney: technique and complications.
S. Huraib (1989)
10.1074/mcp.R200007-MCP200
The Human Plasma Proteome
N. L. Anderson (2002)
10.1111/J.1523-1755.2004.00976.X
Differentiation between chronic rejection and chronic cyclosporine toxicity by analysis of renal cortical mRNA.
K. Koop (2004)
10.1034/j.1600-6143.2003.00135.x
Humoral Theory of Transplantation
P. Terasaki (2003)
10.1002/PMIC.200401048
Zooming in: Fractionation strategies in proteomics
T. Stasyk (2004)
10.1002/PMIC.200500105
Analysis of chronic lung transplant rejection by MALDI‐TOF profiles of bronchoalveolar lavage fluid
Y. Zhang (2006)
10.1006/BBRC.2001.5427
Heat shock proteins: endogenous modulators of apoptotic cell death.
C. Garrido (2001)
10.1016/S0735-1097(98)00257-5
Elevated serum concentrations of cardiac troponin T in acute allograft rejection after human heart transplantation.
T. Dengler (1998)
10.1016/0009-8981(82)90356-4
Comparison of retinol-binding protein and beta 2-microglobulin determination in urine for the early detection of tubular proteinuria.
A. Bernard (1982)
10.1586/14789450.1.4.401
All about DIGE: quantification technology for differential-display 2D-gel proteomics
K. Lilley (2004)
10.1038/nbt0302-301
Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae
S. Ficarro (2002)
10.1097/00007890-199306000-00011
NEUTROPHIL INFILTRATION AS AN IMPORTANT FACTOR IN LIVER ISCHEMIA AND REPERFUSION INJURY
L. Toledo-Pereyra (1993)
10.1126/SCIENCE.1058040
The Sequence of the Human Genome
J. Venter (2001)
10.1002/PMIC.200500770
Proteomic analysis of liver tissues subjected to early ischemia/reperfusion injury during human orthotopic liver transplantation
C. Vascotto (2006)
10.1161/01.CIR.85.1.368
Noninvasive diagnosis of cardiac allograft rejection. Another of many searches for the grail.
J. Hosenpud (1992)
10.1021/PR034059R
Use of proteomics to discover novel markers of cardiac allograft rejection.
S. Borozdenkova (2004)
10.1002/PMIC.200300756
Increases in leukocyte cluster of differentiation antigen expression during cardiopulmonary bypass in patients undergoing heart transplantation
S. Lal (2004)
10.1093/CLINCHEM/28.6.1330
beta 2-Microglobulin instability in pathological urine.
P. Davey (1982)
10.1097/01.SLA.0000064293.57770.42
Characterization of Renal Allograft Rejection by Urinary Proteomic Analysis
W. Clarke (2003)
10.1111/j.1600-6143.2005.00766.x
Proteomic‐Based Identification of Cleaved Urinary β2‐microglobulin as a Potential Marker for Acute Tubular Injury in Renal Allografts
S. Schaub (2005)
10.1097/01.pap.0000175113.55541.9c
Update on Post-Liver Transplantation Infections, Malignancies, and Surgical Complications
K. Washington (2005)
Regulation of actin filament dynamics by p38 map kinase-mediated phosphorylation of heat shock protein 27.
J. Guay (1997)
10.1093/BFGP/4.2.158
Recent advancements in differential proteomics based on stable isotope coding.
Samir Julka (2005)
10.1016/J.HEALUN.2005.05.018
Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult heart transplant report--2005.
D. Taylor (2005)
10.1002/ELPS.1150190526
Use of thiourea to increase the solubility of membrane proteins in two‐dimensional electrophoresis
T. Rabilloud (1998)
10.1002/(SICI)1522-2683(19990101)20:4/5<660::AID-ELPS660>3.0.CO;2-Q
Advances in protein solubilisation for two‐dimensional electrophoresis
B. Herbert (1999)
Characterization of endothelial antigens associated with transplant-associated coronary artery disease.
C. Wheeler (1995)
10.1038/nature01511
Mass spectrometry-based proteomics
R. Aebersold (2003)
10.1038/35057062
Initial sequencing and analysis of the human genome.
E. Lander (2001)
10.1038/13690
Quantitative analysis of complex protein mixtures using isotope-coded affinity tags
Steven P. Gygi (1999)
10.1373/CLINCHEM.2005.051417
Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry.
R. Banks (2005)
10.1016/S1010-7940(00)00565-0
Endothelial apoptosis is induced by serum of patients after cardiopulmonary bypass.
H. Aebert (2000)
10.1002/PMIC.200300624
Optimization of the first dimension for separation by two‐dimensional gel electrophoresis of basic proteins from human brain tissue
K. Pennington (2004)
10.1053/JLTS.2003.50212
Intrahepatic cholestasis after liver transplantation
Z. Ben‐Ari (2003)
10.1002/PMIC.200400970
Increased quantitative proteome coverage with 13C/12C‐based, acid‐cleavable isotope‐coded affinity tag reagent and modified data acquisition scheme
E. Yi (2005)
10.1097/00007890-199805150-00010
A new enzyme-linked immunosorbent assay to measure anti-endothelial antibodies after cardiac transplantation demonstrates greater inhibition of antibody formation by tacrolimus compared with cyclosporine.
Slavica Jurčević (1998)
10.1097/00007890-199902270-00010
Safety of kidney biopsy in pediatric transplantation: a report of the Controlled Clinical Trials in Pediatric Transplantation Trial of Induction Therapy Study Group.
M. Benfield (1999)
10.1074/jbc.274.53.37885
IQGAP1 and Calmodulin Modulate E-cadherin Function*
Z. Li (1999)
10.1097/00001573-199511000-00009
Role of leukotrienes in coronary artery surgery.
S. Allen (1995)
10.1074/jbc.271.28.16510
Small Stress Proteins as Novel Regulators of Apoptosis
P. Mehlen (1996)
10.1097/00007890-200104150-00011
ANTIVIMENTIN ANTIBODIES ARE AN INDEPENDENT PREDICTOR OF TRANSPLANT-ASSOCIATED CORONARY ARTERY DISEASE AFTER CARDIAC TRANSPLANTATION1
Slavica Jurčević (2001)
10.1002/PMIC.200500358
Overview of the HUPO Plasma Proteome Project: Results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly‐available database
G. Omenn (2005)
10.1002/PMIC.200300459
The role of bioinformatics in two‐dimensional gel electrophoresis
A. Dowsey (2003)
10.1002/1522-2683(20000701)21:13<2610::AID-ELPS2610>3.0.CO;2-H
Towards higher resolution: Two‐dimensional Electrophoresis of Saccharomyces cerevisiae proteins using overlapping narrow immobilized pH gradients
R. Wildgruber (2000)
10.1097/00007890-200204270-00013
Decreased serum and bronchoalveolar lavage levels of clara cell secretory protein (CC16) is associated with bronchiolitis obliterans syndrome and airway neutrophilia in lung transplant recipients1
M. Nord (2002)
10.1111/j.1600-6143.2006.01314.x
Contemporary Concepts in Prevention and Treatment of Cardiac Allograft Vasculopathy
M. Mehra (2006)
10.1164/RCCM.200201-003PP
Bronchiolitis obliterans after human lung transplantation.
M. Estenne (2002)
10.1136/thorax.57.7.623
Raised plasma concentrations of α-defensins in patients with idiopathic pulmonary fibrosis
H. Mukae (2002)
10.1074/mcp.M400129-MCP200
Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents*S
P. Ross (2004)
10.1002/1522-2683(200108)22:14<2865::AID-ELPS2865>3.0.CO;2-Y
Zooming‐in on the proteome: Very narrow‐range immobilised pH gradients reveal more protein species and isoforms
J. A. Westbrook (2001)
10.1016/S0140-6736(79)91320-5
URINARY β2-MICROGLOBULIN IN UPPER AND LOWER URINARY-TRACT INFECTIONS
G. Schardijn (1979)
10.1016/J.COPBIO.2004.01.005
SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer.
E. Petricoin (2004)
10.1161/01.CIR.0000136814.87170.B1
Identification by a Differential Proteomic Approach of Heat Shock Protein 27 as a Potential Marker of Atherosclerosis
J. L. Martín-Ventura (2004)
10.1016/J.HEALUN.2007.10.017
Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection.
S. Stewart (2007)
10.1097/01.ASN.0000145241.83482.68
Bioinformatic analysis of the urine proteome of acute allograft rejection.
E. O'Riordan (2004)
10.1016/J.JASMS.2005.02.015
Multidimensional protein identification technology (MudPIT): Technical overview of a profiling method optimized for the comprehensive proteomic investigation of normal and diseased heart tissue
T. Kislinger (2005)
10.1002/PMIC.200600129
The use of mass spectrometry for the proteomic analysis of glycosylation
W. Morelle (2006)
10.1586/14789450.1.3.355
High-throughput proteomics using antibody microarrays
C. Wingren (2004)
10.1136/thorax.58.5.425
Increased concentrations of human β-defensins in plasma and bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis
T. Hiratsuka (2003)
High resolution two-dimensional electrophoresis of proteins.
P. O'Farrell (1975)
10.1038/429496a
Proteomics and cancer: Running before we can walk?
E. Check (2004)
10.1021/PR0340734
Quantification in proteomics through stable isotope coding: a review.
Samir Julka (2004)
10.1074/mcp.M500393-MCP200
Proteomic Analysis of Ischemia-Reperfusion Injury upon Human Liver Transplantation Reveals the Protective Role of IQGAP1*S
A. Emadali (2006)
10.1097/00007890-199610150-00006
Tacrolimus therapy for refractory acute renal allograft rejection: definition of the histologic response by protocol biopsies.
E. Woodle (1996)
10.1002/ELPS.11501601185
Progress with gene‐product mapping of the Mollicutes: Mycoplasma genitalium
V. Wasinger (1995)
10.1016/0016-5085(91)90406-B
Regional orientation of actin filaments in the pericanalicular cytoplasm of rat hepatocytes.
M. Ishii (1991)
10.1002/PMIC.200500516
Identification of new Golgi complex specific proteins by direct organelle proteomic analysis
M. Takatalo (2006)
10.1002/PMIC.200401031
Current two‐dimensional electrophoresis technology for proteomics
A. Görg (2004)
10.1002/path.1958
Array‐based proteomics: mapping of protein circuitries for diagnostics, prognostics, and therapy guidance in cancer
C. Gulmann (2006)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar